13F

Stock

Biomarin Pharmaceutical Inc

BMRN · held by 11 managers

Reported value

$497.9M

Holders

11

+1 new · −0 exited

Holders’ est. mark

−$51.2M

Price effect on 6 books still in the name

Largest holder

$460.4M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC6.76M$460.4M−$49.3MCut−$51M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main15.1M$26.8M−$1.84MCut−$55K
DANSKE BANK A/S105.5K$9.21MHeld
Marex Group plc7.78K$679.3K−$36.9KAdded$287K
Burton Enright Welch3.72K$325.3K−$33.8KCut−$33.9K
Swiss Life Asset Management Ltd3.6K$314.2K−$33.7KCut−$144.4K
Leonteq Securities AG1.47K$128.6K−$2.82KAdded$98.6K

Positions as of Q1 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.